MAPK3 and melanoma: In the second part of our study, knowing that activated kinase V600EBRAF drives the growth factor-independent activation of the ERK1/2 pathway, we also asked the question whether exogenous growth factors are necessary at all for melanoma cell growth, and how lack of them in the culture medium might influence melanoma cell response to targeted therapy.